These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 20011241

  • 1. Noninvasively characterizing the different alphavbeta3 expression patterns in lung cancers with RGD-USPIO using a clinical 3.0T MR scanner.
    Jiang T, Zhang C, Zheng X, Xu X, Xie X, Liu H, Liu S.
    Int J Nanomedicine; 2009; 4():241-9. PubMed ID: 20011241
    [Abstract] [Full Text] [Related]

  • 2. Specific targeting of angiogenesis in lung cancer with RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a 4.7T magnetic resonance scanner.
    Liu C, Liu DB, Long GX, Wang JF, Mei Q, Hu GY, Qiu H, Hu GQ.
    Chin Med J (Engl); 2013 Jun; 126(12):2242-7. PubMed ID: 23786932
    [Abstract] [Full Text] [Related]

  • 3. RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment.
    Kiessling F, Huppert J, Zhang C, Jayapaul J, Zwick S, Woenne EC, Mueller MM, Zentgraf H, Eisenhut M, Addadi Y, Neeman M, Semmler W.
    Radiology; 2009 Nov; 253(2):462-9. PubMed ID: 19789239
    [Abstract] [Full Text] [Related]

  • 4. Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model.
    Zhang C, Liu H, Cui Y, Li X, Zhang Z, Zhang Y, Wang D.
    Int J Nanomedicine; 2016 Nov; 11():1097-108. PubMed ID: 27051285
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gd-EDDA/HYNIC-RGD as an MR molecular probe imaging integrin alphanubeta3 receptor-expressed tumor-MR molecular imaging of angiogenesis.
    Huo T, Du X, Zhang S, Liu X, Li X.
    Eur J Radiol; 2010 Feb; 73(2):420-7. PubMed ID: 19261416
    [Abstract] [Full Text] [Related]

  • 13. Integrin αvβ6-targeted MR molecular imaging of breast cancer in a xenograft mouse model.
    Li D, Dong C, Ma X, Zhao X.
    Cancer Imaging; 2021 Jun 29; 21(1):44. PubMed ID: 34187570
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. RGD-functionalized ultrasmall iron oxide nanoparticles for targeted T₁-weighted MR imaging of gliomas.
    Luo Y, Yang J, Yan Y, Li J, Shen M, Zhang G, Mignani S, Shi X.
    Nanoscale; 2015 Sep 14; 7(34):14538-46. PubMed ID: 26260703
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.